DHR Form 4: Director Teri List Disposes 2,778 Shares
Rhea-AI Filing Summary
Teri List, a director of Danaher Corporation (DHR), reported a sale of 2,778 shares of Danaher common stock on 08/22/2025 at a reported price of $211.058 per share. After the sale, the reporting person beneficially owned 20,750.672 shares, held directly. The Form 4 was signed by an attorney-in-fact on 08/25/2025.
Positive
- Timely compliance with Section 16 reporting requirements: Form 4 filed and signed.
- Clear disclosure of transaction details including date, price, and post-transaction holdings.
Negative
- No disclosure on whether the sale was executed under a Rule 10b5-1 trading plan.
- Lack of context about the reason for the sale limits investor interpretation of intent.
Insights
TL;DR Routine insider sale by a company director; no additional context provided to suggest material impact.
The filing documents a straightforward open-market disposition of 2,778 shares at $211.058, leaving a direct beneficial ownership of 20,750.672 shares. This Form 4 contains no indication of accelerated program sales, option exercises, or derivative transactions. As presented, the transaction appears to be a routine disclosure required under Section 16 and does not, by itself, provide information on company performance or strategy.
TL;DR A director-reported sale was disclosed; filing lacks any statement that it was part of a Rule 10b5-1 plan.
The report marks the sale as a standard Section 16 disclosure. The form does not check the box indicating a 10b5-1 plan or provide remarks explaining the sale's purpose. From a governance perspective, transparent reporting is satisfied, but the absence of plan disclosure means investors cannot determine whether the sale was pre-planned or discretionary.